Medicines (MDCO)/Alnylam (ALNY) to Present Phase 1 Data on siRNA-based PCSK9 Today
Tweet Send to a Friend
Evercore ISI analyst Umer Raffat notes Medicines Co. (NASDAQ: MDCO)/Alnylam Pharma (NASDAQ: ALNY) will present updated Ph 1 data on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
